COLORADO SPRINGS, Colo., Nov. 24, 2014 /PRNewswire/ -- In a move that signals a forceful reinvestment in the largest legal medical cannabis market, Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in global cannabis formulation-based drug development and consulting, has successfully renegotiated its agreement with Apothecary Genetics Investments LLC to purchase and license two northern California production farms with a combined total of 51 acres. The purchase includes all related equipment for cannabis cultivation and production for the state's substantial medical cannabis market.